1 hr ago | World of Psychology
Seroquel XR Gets Additional Approvals
Helping to extend Seroquel's existing reach, AstraZeneca, its maker, has received U.S. Food and Drug Administration approval to market it as an effective treatment not only for mania associated with bipolar ...
17 hrs ago | Boston Globe
1 killed, 1 hurt in accident at job site
The lift at the AstraZeneca campus tipped over when the men were about 30 feet in the air.
Nashua man killed in Mass. construction accident
A Nashua, N.H., man was killed and another construction worker seriously injured when a hydraulic lift tipped over at a project at a pharmaceutical company yesterday, according to police.
Nashua Man Killed In Industrial Incident In Massachusetts
One worker was killed and another injured Friday in an industrial incident at a building in Waltham, Mass.
FDA Approves AstraZeneca's Seroquel XR for the Treatment of...
AstraZeneca today announced that the US Food and Drug Administration has approved once-daily SEROQUEL XR Extended-Release Tablets for the acute treatment of the depressive episodes associated with bipolar ...
Zacks Analyst Blog Highlights: AstraZeneca PLC, Phase Forward,...
Zacks Analyst Blog Highlights: AstraZeneca PLC, Phase Forward, Omnicom Group, Acorda Therapeutics and Digital River, Inc.
Heartburn, insomnia lead drugmaker Web sites
Popular prescriptions for heartburn, diabetes and insomnia led people to pharmaceutical company Web sites in the second quarter, says a report from comScore Inc.
Cancer network study includes RPCI
Roswell Park Cancer Institute will receive funding to enable additional studies on anti-cancer drugs.
At $6.5 billion , ImClone isn't coming all that cheap, but Eli Lilly really needs ImClone's Erbitux and pipeline and is clearly willing to pay for it.
CTS inaugurates Budapest centre
CHENNAI: Cognizant Technology Solutions, a global consulting, technology and business process services provider has inaugurated its delivery centre in Budapest, Hungary.
NCCN, Abraxis BioScience and AstraZeneca Announce Collaboration to Conduct Anti-Cancer Drug Studies
The NCCN studies will evaluate ABRAXANE in the treatment of breast, non-small cell lung, head and neck, melanoma and ovarian cancers.
New Review Supports Use Of Formoterol In Children And Adolescents With Asthma
Main Category: Respiratory / Asthma Also Included In: Pediatrics / Children's Health ; Regulatory Affairs / Drug Approvals Article Date: 07 Oct 2008 - 4:00 PDT A new review of the long acting beta2-agonist ...
MedImmune licenses reverse genetics technology to Japan's BIKEN for...
MedImmune licenses reverse genetics technology to Japan's BIKEN for use in influenza vaccine development M2Europharma on Monday, 29 September 2008 at 19:58 GMT 29 September 2008 MedImmune, wholly-owned by ...
Palatin Technologies, Inc. F4Q08 Call Transcript
Palatin Technologies, Inc. F4Q08 Earnings Call September 30, 2008 11:00 am ET Executives Carl Spana, Ph.D. - " President and Chief Executive Officer Stephen T. Wills - Chief Financial Officer Trevor Hallam, ...
Federal Judge Certifies Two Nationwide Classes in Wholesale Drug Pricing Case
A federal judge in Boston certified two nationwide classes and set the stage for two more trials in the massive, multidistrict wholesale drug pricing case against AstraZeneca and Bristol-Myers Squibb Co.
Moody's Gets Moody With Drugmakers
European businesses probably wish they could cut back on their imports of bad news from the U.S. this month.
Cubist expands lab research facility
Cubist Pharmaceuticals Inc. has opened its new 35,000-square-foot research facility at the company's biopharmaceutical headquarters in Lexington.
Astra, Pfizer get statins all-clear
Drug giants AstraZeneca and Pfizer have received a boost for their cholesterol-lowering medicines after a US report said they do not increase the risk of the neurological disorder known as Lou Gehrig's disease.
Israel Stocks: Tel Aviv higher; Teva forms Japan venture, loses legal round
Israeli stocks traded broadly higher on Wednesday, led by banks, Teva Pharmaceutical Industries and real-estate companies.
4-Antibody Appoints Dr. Richard Mason as New Chief Executive Officer
Sep 26, 2008 - 4-Antibody AG today announced that Dr. Richard Mason has joined the company as Chief Executive Officer and Geschaeftsfuehrer.